title: Plasma free 25-hydroxyvitamin D, vitamin D binding protein, and risk of breast cancer in the Nurses' Health Study II.
abstract: OBJECTIVE
  Prior prospective studies, including our own, have evaluated total plasma 25-hydroxyvitamin D [25(OH)D] and breast cancer risk with inconsistent results. However, recent studies suggest that some vitamin D functions may be more relevant to the unbound (free) fraction of 25(OH)D. Vitamin D binding protein (DBP) influences the free 25(OH)D levels and thus possibly the biological activities of vitamin D.
  
  
  METHODS
  We conducted a case-control study nested within the Nurses' Health Study II to evaluate the association of plasma free 25(OH)D and DBP with breast cancer risk in predominantly premenopausal women. Plasma samples were assayed for 25(OH)D and DBP in 584 case-control pairs. Free 25(OH)D levels were calculated based on plasma levels of total 25(OH)D, DBP, and a constant value representing average albumin levels. Conditional logistic regression was used to estimate relative risks (RRs) and 95% confidence intervals (CIs).
  
  
  RESULTS
  We found no association between plasma calculated free 25(OH)D and risk of breast cancer overall (highest vs. lowest quartile RR 1.21, 95% CI 0.83-1.77, trend test p value = 0.50). No association was observed for plasma DBP as well (highest vs. lowest quartile RR 0.95, 95% CI 0.67-1.36, trend test p value = 0.96). Results were similar by tumor hormone receptor status. Neither the total nor the calculated free 25(OH)D and breast cancer association substantially varied by plasma DBP levels.
  
  
  CONCLUSIONS
  Our study does not support an important role of either calculated circulating free 25(OH)D or circulating DBP levels in breast cancer risk among predominantly premenopausal women.
authors.affiliation: Division of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts Amherst, 715 N. Pleasant Street, Amherst, MA, 01003, USA, junw@schoolph.umass.edu.
authors.forename: Jun
authors.initials: J
authors.lastname: Wang
authors.forename: A Heather
authors.initials: AH
authors.lastname: Eliassen
authors.forename: Donna
authors.initials: D
authors.lastname: Spiegelman
authors.forename: Walter C
authors.initials: WC
authors.lastname: Willett
authors.forename: Susan E
authors.initials: SE
authors.lastname: Hankinson
mesh_terms: D000328:Adult; D001943:Breast Neoplasms / Q000097:blood* / Q000453:epidemiology; D002117:Calcitriol / Q000097:blood*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D008875:Middle Aged; D017697:Premenopause; D012307:Risk Factors; D014809:Vitamin D-Binding Protein / Q000097:blood*
chemical_list: D014809:Vitamin D-Binding Protein; D002117:Calcitriol
references.citation: Cancer Res. 2006 Feb 15;66(4):2476-82
references.pmid: 16489055
references.citation: J Bone Miner Res. 2011 Jul;26(7):1609-16
references.pmid: 21416506
references.citation: Development. 2002 Jul;129(13):3067-76
references.pmid: 12070083
references.citation: J Clin Endocrinol Metab. 1986 Oct;63(4):954-9
references.pmid: 3745408
references.citation: Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1222-5
references.pmid: 22623707
references.citation: J Natl Cancer Inst. 2008 Nov 19;100(22):1581-91
references.pmid: 19001601
references.citation: Br J Cancer. 2012 Oct 23;107(9):1589-94
references.pmid: 22990651
references.citation: Int J Cancer. 2013 Oct 1;133(7):1689-700
references.pmid: 23526380
references.citation: Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2655-60
references.pmid: 19789365
references.citation: Breast Cancer Res. 2009;11(4):R64
references.pmid: 19715600
references.citation: J Nutr. 2008 Jul;138(7):1323-8
references.pmid: 18567755
references.citation: Breast Cancer Res. 2012 May 31;14(3):211
references.pmid: 22676419
references.citation: Stat Med. 1985 Jul-Sep;4(3):337-44
references.pmid: 4059720
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1991-7
references.pmid: 16103450
references.citation: Medicine (Baltimore). 2013 May;92(3):123-131
references.pmid: 23625163
references.citation: J Clin Invest. 1999 Jan;103(2):239-51
references.pmid: 9916136
references.citation: Int J Cancer. 2010 Nov 1;127(9):2159-68
references.pmid: 20112341
references.citation: J Clin Endocrinol Metab. 1985 Nov;61(5):969-75
references.pmid: 3840175
references.citation: Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2341-50
references.pmid: 20826834
references.citation: Cancer Causes Control. 2013 Mar;24(3):495-504
references.pmid: 23296455
references.citation: J Nutr. 2006 Nov;136(11):2754-9
references.pmid: 17056796
references.citation: Kidney Int. 2012 Jul;82(1):84-9
references.pmid: 22398410
references.citation: Stat Med. 2007 Sep 10;26(20):3735-52
references.pmid: 17538974
references.citation: Breast Cancer Res. 2013 Feb 26;15(1):R15
references.pmid: 23442740
references.citation: Am J Clin Nutr. 2008 Apr;87(4):1087S-91S
references.pmid: 18400739
references.citation: Trends Endocrinol Metab. 2000 Oct;11(8):320-7
references.pmid: 10996527
references.citation: Mol Cell Endocrinol. 2010 Mar 5;316(1):93-102
references.pmid: 19646505
references.citation: Cancer Epidemiol Biomarkers Prev. 1996 Feb;5(2):121-6
references.pmid: 8850273
references.citation: Endocr Rev. 1989 Aug;10(3):232-74
references.pmid: 2673754
references.citation: Cancer Epidemiol Biomarkers Prev. 1995 Sep;4(6):655-9
references.pmid: 8547833
references.citation: Stat Med. 1989 May;8(5):551-61
references.pmid: 2657958
references.citation: Int J Cancer. 2014 Jun 1;134(11):2699-706
references.pmid: 24214881
references.citation: J Clin Epidemiol. 1995 Sep;48(9):1141-52
references.pmid: 7636516
references.citation: Int J Cancer. 2013 Jun 15;132(12):2940-7
references.pmid: 23180681
references.citation: Cancer Res. 2012 Mar 1;72(5):1190-8
references.pmid: 22232734
references.citation: Breast Cancer Res. 2011 May 11;13(3):R50
references.pmid: 21569367
references.citation: Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):889-94
references.pmid: 18381472
references.citation: Eur J Cancer. 2010 Feb;46(3):467-70
references.pmid: 20022237
references.citation: Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):938-46
references.pmid: 20332276
references.citation: J Clin Invest. 1981 Mar;67(3):589-96
references.pmid: 6894152